Home / Science

Science

FDA Approves Jardiance and Synjardy for Enhancing Blood Sugar Control in Pediatric Type 2 Diabetes Patients

FDA Approves Jardiance and Synjardy for Enhancing Blood Sugar Control in Pediatric Type 2 Diabetes Patients

The U.S. Food and Drug Administration granted approval to Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as supplementary treatments to diet and exercise. These medications aim to enhance blood sugar control in children aged 10 years and above who are diagnosed with type 2 diabetes. This recent approval signifies ...

Read More »